Meningeal Lymphatic System-Driven Nanodelivery Unlocks Ursolic Acid’s Pleiotropic Benefits To Optimize Multiple Sclerosis Treatment
ACS Nano · 17.02.2026 · 20 (6) · 4782-4798
DOI: 10.1021/acsnano.5c16373 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 02.02.2026. Verfasst von Xiyu Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fudan University, National Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Key Laboratory of Smart…. Hauptthemen laut MEDLINE: Triterpenes, Multiple Sclerosis, Nanoparticles, Meninges. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China, State Key Laboratory of Neurology and Oncology Drug Development.
Abstract (Originalsprache)
Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system (CNS), characterized by peripheral immune cells infiltration, neuroinflammation, and demyelination. Addressing complex pathological mechanisms and spatially multifocal lesions, including deep cervical lymph nodes (dCLNs), meningeal lymphatic vessels (MLVs), and the brain parenchyma, remains a major challenge in MS treatment. Here, we present a streamlined nanotherapeutic strategy using self-assembled ursolic acid nanoparticles (UA-NPs) administered via near-neck subcutaneous injection (n.s.c.). This route strategically exploits the dCLNs-MLVs pathway, anatomically aligned with the multifocal nature of MS lesions, while it is capable of bypassing the blood-brain barrier. Multiple lines of experimental evidence collectively demonstrates that n.s.c. UA-NPs achieve (1) enhanced accumulation in key immune interfaces related to MS, specifically the dCLNs and MLVs, as well as in the brain parenchyma, remarkably outperforming intravenous injection; (2) prolonged cerebral residence time (n.s.c. 48 h vs i.v. 8 h) while minimizing systemic exposure; (3) unlocked the multipharmacological potential of ursolic acid, achieving immunomodulation, inflammation suppression, and myelin repair that correspond to MS pathology. Consequently, n.s.c. UA-NPs reverse various MS-related behavioral disorders, offering a minimalist, yet multifunctional therapeutic paradigm with spatial precision that surpasses conventional approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Fudan University, National Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, P. R. China.
- Cancer Centre and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR 999078, P. R. China.
- Neurovascular Center, Changhai Hospital, Naval Medical University, Key Laboratory of Molecular Neurobiology of Ministry of Education, Shanghai 200433, P. R.China.
- State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing 210042, P. R. China.
- Pharmacy Department & Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, P. R. China.
Förderung
- National Natural Science Foundation of China
- State Key Laboratory of Neurology and Oncology Drug Development
Zitieren
APA
Yang, X., Meng, R., Liu, X., Li, Y., Wang, T., Yan, Z., Zhou, L., Zhang, X., Yang, P., & Zhang, Q. (2026). Meningeal Lymphatic System-Driven Nanodelivery Unlocks Ursolic Acid’s Pleiotropic Benefits To Optimize Multiple Sclerosis Treatment. ACS Nano, 20(6), 4782-4798. https://doi.org/10.1021/acsnano.5c16373
Vancouver
Yang X, Meng R, Liu X, Li Y, Wang T, Yan Z, et al. Meningeal Lymphatic System-Driven Nanodelivery Unlocks Ursolic Acid’s Pleiotropic Benefits To Optimize Multiple Sclerosis Treatment. ACS Nano. 2026;20(6):4782-4798. doi:10.1021/acsnano.5c16373
BibTeX
@article{Yang2026,
author = {Yang, Xiyu and Meng, Ran and Liu, Xuan and Li, Yixian and Wang, Tianying and Yan, Ziliang and Zhou, Lingling and Zhang, Xinyi and Yang, Peng and Zhang, Qizhi},
title = {Meningeal Lymphatic System-Driven Nanodelivery Unlocks Ursolic Acid’s Pleiotropic Benefits To Optimize Multiple Sclerosis Treatment},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {6},
pages = {4782--4798},
doi = {10.1021/acsnano.5c16373}
}
EUVIMED